Blackstone Raises $6.3B Life Sciences Fund Record
NEW YORK & CAMBRIDGE, Mass., USA, March 30, 2026 Blackstone has announced the final close of Blackstone Life Sciences...
drug development
Advertisement
Insilico, Lilly Sign $2.75B AI Drug Discovery Deal
Hong Kong | March 30, 2026 Strategic AI Collaboration to Accelerate Drug Discovery Insilico Medicine has announced a major...
AI Drug Discovery Deal Expands CNS Pipeline Value
Hong Kong | March 30, 2026 AI Collaboration Accelerates CNS Drug Discovery Insilico Medicine and Tenacia Biotechnology have announced...
Lupin Gets FDA Nod for Pitolisant Tablets
MUMBAI, INDIA & NAPLES, USA | March 25, 2026 Lupin Limited, a global pharmaceutical leader, has received tentative approval...
Gilgamesh Pharma Raises $60M for Neuro Therapies
NEW YORK, USA | March 24, 2026 Gilgamesh Pharma, a clinical-stage neuroscience company focused on next-generation neuropsychiatric therapeutics, has...
Advertisements
Apogee Therapeutics Prices $350M Public Offering
SAN FRANCISCO & BOSTON, USA | March 24, 2026 Apogee Therapeutics, Inc. has successfully announced the pricing of its...
Gilead to Acquire Ouro for $2.1B Autoimmune Pipeline Boost
FOSTER CITY, CALIFORNIA, March 24, 2026 Gilead Sciences has announced a definitive agreement to acquire Ouro Medicines in a...
Sun Pharma Launches Semaglutide in India Market
MUMBAI, INDIA, March 21, 2026 Sun Pharmaceutical Industries Limited has announced the launch of its semaglutide injection under the...
AI Transforms Pharma R&D and Manufacturing Models
London, United Kingdom | March 23, 2026 The pharmaceutical industry is undergoing a profound transformation as artificial intelligence (AI),...
Innovent Doses First Patient in Phase 3 IBI128 Trial
San Francisco, USA / Suzhou, China | March 22, 2026 Innovent Biologics has announced that the first participant has...
Advertisement
